Literature DB >> 7719904

Time to peak serum antibody response to influenza vaccine.

S Rastogi1, P A Gross, J Bonelli, S Dran, R A Levandowski, C Russo, M E Weksler, D Kaye, M Levison, E Abrutyn.   

Abstract

The time to the appearance of a peak serum antibody response to influenza virus vaccine is not clearly defined. We compared the most commonly used time intervals described in the literature--4 and 6 weeks after vaccination. We studied 118 elderly patients from three different geographic sites. The 1992 to 1993 trivalent inactivated influenza virus vaccine containing influenza virus A/Beijing/353/89 (H3N2), influenza virus A/Texas/36/91 (H1N1), and influenza virus B/Panama/45/90 was used. No statistically significant differences were found at the 4- and 6-week intervals after vaccination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719904      PMCID: PMC170112          DOI: 10.1128/cdli.2.1.120-121.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  4 in total

1.  Association of influenza immunization with reduction in mortality in an elderly population. A prospective study.

Authors:  P A Gross; G V Quinnan; M Rodstein; J R LaMontagne; R A Kaslow; A J Saah; S Wallenstein; R Neufeld; C Denning; P Gaerlan
Journal:  Arch Intern Med       Date:  1988-03

Review 2.  Critical appraisal of emulsified oil adjuvants applied to viral vaccines.

Authors:  M R Hilleman
Journal:  Prog Med Virol       Date:  1966

3.  Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and Trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines.

Authors:  M W Brandriss; R F Betts; U Mathur; R G Douglas
Journal:  Am Rev Respir Dis       Date:  1981-12

4.  A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children.

Authors:  P A Gross; F A Ennis; P F Gaerlan; L J Denson; C R Denning; D Schiffman
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

  4 in total
  10 in total

1.  Time to earliest peak serum antibody response to influenza vaccine in the elderly.

Authors:  P A Gross; C Russo; S Dran; P Cataruozolo; G Munk; S C Lancey
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Alan L Rothman; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-02-26       Impact factor: 3.641

3.  Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children.

Authors:  Sophia Ng; Vicky J Fang; Dennis K M Ip; Kwok-Hung Chan; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

4.  Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents.

Authors:  Eun Kyeong Kang; Byung Wook Eun; Nam Hee Kim; Yun Kyung Kim; Jung Sub Lim; Dong Ho Kim
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

5.  Time to peak serum antibody response to influenza vaccine in the elderly.

Authors:  P A Gross; C Russo; M Teplitzky; S Dran; P Cataruozolo; G Munk
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

6.  No Effect of Acute Eccentric Resistance Exercise on Immune Responses to Influenza Vaccination in Older Adults: A Randomized Control Trial.

Authors:  Mahmoud T Elzayat; Melissa M Markofski; Richard J Simpson; Mitzi Laughlin; Emily C LaVoy
Journal:  Front Physiol       Date:  2021-08-12       Impact factor: 4.566

7.  Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning.

Authors:  Jon Zelner; Joshua G Petrie; Rob Trangucci; Emily T Martin; Arnold S Monto
Journal:  J Infect Dis       Date:  2019-06-05       Impact factor: 7.759

8.  Individual and Population Trajectories of Influenza Antibody Titers Over Multiple Seasons in a Tropical Country.

Authors:  Xiahong Zhao; Yilin Ning; Mark I-Cheng Chen; Alex R Cook
Journal:  Am J Epidemiol       Date:  2018-01-01       Impact factor: 4.897

9.  Influenza Vaccine Effectiveness among Elementary School Students in Korea during the 2016-2017 Seasons: a Cross-Sectional Survey.

Authors:  Yoon Mo Kim; Sol Kang; Jung Sub Lim; Dong Ho Kim
Journal:  J Korean Med Sci       Date:  2020-02-10       Impact factor: 2.153

10.  An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderly.

Authors:  Elettra Fallani; Andrea Orsi; Alessio Signori; Giancarlo Icardi; Alexander Domnich
Journal:  Hum Vaccin Immunother       Date:  2021-12-29       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.